in march 2017, scientists at the university of tasmania presented an apparent first report of having successfully treated tasmanian devils with the disease, by injecting live cancer cells into the infected devils to stimulate their immune system to recognise and fight the disease. in 2019, researchers from university sydney reported constricted diversity of the t cell repertoire in devils with dftd, suggesting that dftd may impact the host immune system directly.